Cytosorbents
CTSO
#9904
Rank
HK$0.30 B
Marketcap
HK$4.92
Share price
-4.43%
Change (1 day)
-36.86%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -HK$98.34 Million

According to Cytosorbents's latest financial reports the company's current earnings are HK$36.97 Million. In 2024 the company made an earning of -HK$0.18 Billion, an increase over its 2023 earnings that were of -HK$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$98.34 Million-44.61%
2024 -HK$0.18 Billion-22.49%
2023 -HK$0.23 Billion-13.52%
2022 -HK$0.27 Billion34.04%
2021 -HK$0.2 Billion182.17%
2020 -HK$70.04 Million-55.97%
2019 -HK$0.16 Billion14.17%
2018 -HK$0.14 Billion95.14%
2017 -HK$71.39 Million-22.32%
2016 -HK$91.9 Million39.1%
2015 -HK$66.07 Million-12.89%
2014 -HK$75.85 Million89%
2013 -HK$40.13 Million26.65%
2012 -HK$31.69 Million-26.02%
2011 -HK$42.83 Million-288.45%
2010 HK$22.72 M-4.17%
2009 HK$23.71 M-287.19%
2008 -HK$12.67 Million-47.12%
2007 -HK$23.96 Million41.78%
2006 -HK$16.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
HK$25.54 B-25,894.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
HK$6.23 B-6,397.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
HK$0.43 B-537.85%๐Ÿ‡บ๐Ÿ‡ธ USA